SecBot SecBot
144 ·Filed May 8, 2026

ARVN

ARVINAS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001628280-26-033077
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is mandatory for tax purposes and does not reflect a change in insider outlook. Monitor for any discretionary insider sales or changes in holding patterns. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$9.66
T+0 close · May 8, 2026 · via day close
Latest settled
−13.04%
T+60 · $8.40
Vs SPY
−17.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 11 $9.66entry
  2. T+1 · 6mo ago −0.93%α −0.80% · $9.57
  3. T+5 · 6mo ago −9.11%α −9.02% · $8.78
  4. T+20 · 5mo ago −25.36%α −25.06% · $7.21
  5. T+60 · 3mo ago −13.04%α −17.44% · $8.40

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Noah Berkowitz, an officer of Arvinas, filed a Form 144 to sell 11,312 shares (approx. $114K) on May 11, 2026, solely to cover withholding taxes upon vesting of restricted stock units. This is a non-discretionary, routine transaction that is not indicative of insider sentiment.

Key Facts

  • Insider: Noah Berkowitz (Officer)
  • Shares to be sold: 11,312
  • Aggregate market value: $114,364.32 (based on May 8, 2026 closing price)
  • Planned sale date: May 11, 2026
  • Sale purpose: Automatic to cover withholding taxes upon RSU vesting
  • Not a discretionary trade

Financial Impact

Minimal; ~0.017% of market cap ($657M)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
62% bullish (26 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-033077
Document: 0001628280-26-033077-index.html0001628280-26-033077
Document: 0001628280-26-033077.txt0001628280-26-033077

Track record

21 reports on ARVN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +28.62% at T+60 after the Feb 23, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 3, 202613d ago S-3 Bearish 5/10 Entry $7.42 to $6.55 Now $6.77 +8.76% ▲ +11.73% +7.32% vs SPY
  2. Nov 3, 202613d ago 8-K Bearish 5/10 No price data
  3. Nov 3, 202613d ago Press Release Neutral 4/10 Entry $7.09 to $7.42 Now $6.77 −4.51% ▲ +4.65% +3.00% vs SPY
  4. Sep 4, 202610w ago 144 Neutral 3/10 Entry $9.08 to $8.76 Now $6.77 −25.44% ▼ −3.52% −3.06% vs SPY
  5. Jun 22, 202621w ago 8-K Neutral 3/10 Entry $8.14 to $8.05 Now $6.77 −16.83% ▼ −1.11% −1.06% vs SPY
  6. Jun 2, 202623w ago 8-K Bearish 6/10 Entry $7.70 to $7.74 Now $6.77 +12.08% ▼ −0.52% −0.12% vs SPY
  7. May 12, 202626w ago 8-K Mixed 6/10 No price data
  8. May 12, 202626w ago 8-K Bullish 7/10 Entry $9.57 to $9.87 Now $6.77 −29.26% ▲ +3.13% +2.56% vs SPY
  9. May 12, 202626w ago Press Release Bearish 8/10 Entry $9.57 to $9.87 Now $6.77 +29.26% ▼ −3.13% −2.56% vs SPY
  10. May 8, 202627w ago 144 Neutral 2/10 Entry $9.66 to $9.57 Now $6.77 −29.92% ▼ −0.93% −0.80% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026